World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
56040
World Ranking
5907
National Ranking
3166

Kevin L. Winthrop publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kevin L. Winthrop sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 644 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kevin L. Winthrop D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kevin L. Winthrop sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kevin L. Winthrop is affiliated with Oregon Health & Science University in the United States. Their research primarily focuses on a range of topics within medicine, with a specialization in rheumatology, epidemiology, infectious diseases, immunology, and hematology.

Their work centers on key topics including:

  • Rheumatoid Arthritis Research and Therapies
  • Mycobacterium research and diagnosis
  • Tuberculosis Research and Epidemiology
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Psoriasis: Treatment and Pathogenesis

Kevin L. Winthrop has contributed to publications in a diverse range of high-impact venues, frequently publishing in:

  • Annals of the Rheumatic Diseases
  • CHEST Journal
  • Arthritis & Rheumatology
  • Open Forum Infectious Diseases
  • RMD Open

Their recent papers include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (2022, Annals of the Rheumatic Diseases)
  • Neutralizing monoclonal antibodies for treatment of COVID-19 (2021, Nature reviews. Immunology)
  • Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline (2020, European Respiratory Journal)
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020, Clinical Infectious Diseases)

Frequent co-authors collaborating with Kevin L. Winthrop include:

  • Gerd R Burmester
  • Yoshiya Tanaka
  • Jeffrey R. Curtis
  • Tsutomu Takeuchi
  • Daniel Aletaha

Kevin L. Winthrop's work spans multiple subfields of medicine, demonstrating expertise in rheumatology, epidemiology, infectious diseases, immunology, and hematology. Their publications contribute to ongoing research and treatment strategies related to autoimmune and inflammatory disorders, infectious pulmonary diseases, and hematologic conditions.

Best Publications

  • An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

    David E. Griffith;Timothy Aksamit;Barbara A. Brown-Elliott;Antonino Catanzaro

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis

  • Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

    Charles L. Daley;Jonathan M. Iaccarino;Christoph Lange;Emmanuelle Cambau

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

    Maxime Dougados;Martin Soubrier;Anna Antunez;Peter Balint

  • The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

    Wouter Hoefsloot;Jakko Van Ingen;Claire Andrejak;Kristian Ängeby

  • Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

    Sofia Ramiro;Cécile Gaujoux-Viala;Jackie L Nam;Jackie L Nam;Josef S Smolen

  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

    Charles L Daley;Jonathan M Iaccarino;Christoph Lange;Emmanuelle Cambau

  • Neutralizing monoclonal antibodies for treatment of COVID-19.

    Peter C. Taylor;Andrew C. Adams;Matthew M. Hufford;Inmaculada de la Torre

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • The emerging safety profile of JAK inhibitors in rheumatic disease

    Kevin L. Winthrop

  • European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

    L Gossec;J S Smolen;C Gaujoux-Viala;Z Ash

  • US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

    R. Andres Floto;R. Andres Floto;Kenneth N. Olivier;Lisa Saiman;Charles L. Daley

  • Pulmonary Nontuberculous Mycobacterial Disease Prevalence and Clinical Features An Emerging Public Health Disease

    Kevin L. Winthrop;Erin McNelley;Brian Kendall;Allison Marshall-Olson

  • Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology.

    P. Maureen Cassidy;Katrina Hedberg;Ashlen Saulson;Erin McNelly

  • Infection Risk and Safety of Corticosteroid Use

    Jameel Youssef;Shannon A. Novosad;Kevin L. Winthrop

  • The role of IL-6 in host defence against infections: immunobiology and clinical implications

    Stefan Rose-John;Kevin Winthrop;Leonard Calabrese

  • Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

    J. L. Nam;K. L. Winthrop;R. F. Van Vollenhoven;K. Pavelka

  • Erratum: The emerging safety profile of JAK inhibitors in rheumatic disease

    Kevin L. Winthrop

Frequent Co-Authors

Jeffrey R. Curtis
Jeffrey R. Curtis University of Alabama at Birmingham
John W. Baddley
John W. Baddley University of Alabama at Birmingham
Charles L. Daley
Charles L. Daley National Jewish Health
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Kenneth N. Olivier
Kenneth N. Olivier National Institutes of Health
Mark C. Genovese
Mark C. Genovese Stanford University
Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Paul Emery
Paul Emery University of Leeds
Maxime Dougados
Maxime Dougados Hôpital Cochin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a wide range of related healthcare degrees and pathways. For registered nurses looking to advance their skills, rn to fnp bridge programs provide an efficient route to become a Family Nurse Practitioner through flexible online study.

If you’re interested in nutrition and its impact on health, the best online food science degree programs can prepare you for careers in dietetics, research, or healthcare consulting. These online options allow you to balance education with work or other commitments.

Leadership roles in hospitals and clinics often require specialized education in administration. It’s important to seek which online healthcare administration programs have cahme accreditation? CAHME accreditation ensures the highest standards in healthcare management education, increasing your employment prospects in the field.

For nurses seeking advancement without additional clinical hours, consider rn to bsn programs without clinicals. These programs deliver key theoretical knowledge online and help you upgrade your credentials while accommodating busy schedules.

Best Scientists Citing Kevin L. Winthrop

Trending Scientists